Search Results - "Nuzzo, P.V."
-
1
-
2
-
3
Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study
Published in Annals of oncology (01-08-2022)“…COVID-19 disproportionately impacted patients with cancer as a result of direct infection, and delays in diagnosis and therapy. Oncological clinical trials are…”
Get full text
Journal Article -
4
LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)
Published in Annals of oncology (01-09-2020)Get full text
Journal Article -
5
108P Targeting de novo lipogenesis synergizes with androgen-receptor inhibitors in castration-resistant prostate cancer
Published in ESMO open (01-02-2024)Get full text
Journal Article -
6
Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes
Published in Annals of oncology (01-05-2015)Get full text
Journal Article -
7
Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC)
Published in Annals of oncology (01-10-2019)Get full text
Journal Article -
8
976P - Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC)
Published in Annals of oncology (01-10-2019)“…An elevated BMI is associated with improved prognosis in certain solid tumors treated with ICI; however, real-world data and genomic analysis has been lacking…”
Get full text
Journal Article -
9
Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC)
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
10
The Prognostic Value of Periostin Expression in Human Prostate Cancer
Published in Annals of oncology (01-09-2012)Get full text
Journal Article -
11
-
12